Hypertensive disorders during pregnancy associated with lower breastfeeding rates

Hypertensive disorders during pregnancy (HDP) – such as chronic or pregnancy of hypertension, preeclampsia and eclampsia – are among the main causes of mother and infant death in the United States.

Between 2017 and 2019, 16% of all US pregnancy is complicated by a diagnosis of HDP, with much higher rates observed between non -Spanish black/African and American Indian/Alas. But HDPs do not only affect women in the short term. These disorders can increase the long -term risk of heart disease, kidney disease and stroke.

But there could be an opportunity to mitigate these long -term risks to breastfeeding, they have found Yale researchers. In a new study, they found that a diagnosis of HDP before or during pregnancy associated with a higher chance of never breastfeeding or those who started breastfeeding, more likely to stop. The findings indicate that women with HDPS can benefit from targeted interventions promoting their exposure to the cardioprotective benefits of breastfeeding.

Findings are published in the magazine Open the Jama Network.

We examined breastfeeding starting or if you ever started breastfeeding. We also examined the duration of breastfeeding. So if you started, how long did you breastfeed? The existence of hypertensive pregnancy disorder was associated with worse results for both measures. ”

Deanna Nardella, Pediatrics and Doctor-Scientist Trainer with Yale Medical School (YSM) and first author of the study

There may be many obstacles to starting and maintaining, postpartum breastfeeding, from addressing lactation challenges and inadequate parental leave policies in lack of breastfeeding between patients and health care providers. In the US, 83% of women begin breastfeeding, according to diseases of disease control and prevention, but only 25% continue to breastfeed exclusively in the first six months – the recommended duration from leading health organizations.

“These statistics ask the question. Why is this?” Nardella said. “As a pediatrician in the New Haven community. I don’t often see parents who really don’t want to breastfeed.

“Unfortunately, many families do not receive the timely care they need to face such challenges, resulting in lactation cessation. I believe that the friction we see in US breastfeeding rates, especially within the first weeks to months after childbirth, largely reflects the issues of systems.”

Other maternal co -hosts, including chronic and gestational diabetes, have been shown to adversely affect breastfeeding effects, but few are known for the effects of breastfeeding for those with HDP despite their high prevalence between pregnant women in the United States. For Nardella, understanding this relationship is critical for promoting equality of health.

“We know that black and inherent women in the US have higher rates of hypertensive pregnancy disorders,” he said. “These communities also have the lowest breastfeeding rates, although we cannot say that HDPs directly cause these observed inequalities, understanding the mechanisms of the relationship between HDP and starting and breastfeeding duration could promote more fair long -term cardirals and long -term cardirals.”

For the new study, the researchers tried to better understand this relationship by analyzing the data from the Risk Evaluation System (CDC) Centers for Disease Control and Prevention (CDC) (PRM). Prams investigates women in all the US, usually about four months after childbirth, their postures, beliefs and experiences during their periods for pregnancy, prenatal and postpartum.

Their sample included women who had delivered a living infant from January 2016 and November 2021 and who had provided full details of HDP and non -launch or pause of breastfeeding. Researchers determined HDP as self -reported high blood pressure or hypertension, preeclampsia or eclampsia before or during pregnancy. Women were determined to never breastfeed if they reported “no” to breastfeed in the research. Among those who reported breastfeeding, the researchers determined the time for the cessation of up to 0.5 weeks if they reported breastfeeding less than a week, the exact duration of their breastfeeding (in weeks) if predicted or infant age at the time of completion of the investigation (in weeks) if they were reported.

Their detailed sample included 205,247 participants – a weighted sample representing nearly 11 million US women – from 43 states, Washington, DC and Puerto Rico and in all socio -economic, racial and ethnic backgrounds. They found that women with HDP were 11% higher chance of never breastfeeding and, among those who began to breastfeed, 17% higher chance of stopping at some point during the postpartum period. The average time to stop breastfeeding was 17 weeks shorter for women with HDP than those without HDP. These findings indicate a negative correlation between HDP results and breast -feeding.

“More than 80% of US families choose to breastfeed their infant,” said Sarah Taylor, Professor of Pediatrics (neonatal-practicing medicine) in YSM and co-author of the study. “However, most do not reach the target set by the American Academy of Pediatrics, to exclusively breastfeed for six months.

Future studies to identify the mechanisms that form the basis of this relationship between HDP and breastfeeding are required to develop targeted, innovative strategies to improve breastfeeding results for people with HDP, the researchers said.

“Such strategies could include a standard, dedicated prenatal lactation advice for people who want to try breastfeeding and have risk factors to experience worse breastfeeding results, such as HDP,” Nardella said. “Pregnancy is a critical and often inadequate, time for education and support of lactation.”

He added: “This document provides fundamental knowledge to build future studies to understand how our health systems can better support these people with hypertension to achieve their personal goals for infants’ nutrition. Cardiomatomal disease and pause.”

The study was supported by grants by the Yale Pediatric Scholars program, the Yale National Clinics Program and the Awards of Clinical and Translation Sciences from the National Translation Science Promotion Center, part of the National Institutes of Health (NIH).